Education
About Us
Working with TipRanks
Follow Us
Symbio Pharmaceuticals Limited (JP:4582)
:4582
4582 Stock Chart & Stats
¥125.00
¥6.00(2.96%)
At close: 4:00 PM EST
¥125.00
¥6.00(2.96%)
Day’s Range― - ―
52-Week Range¥114.00 - ¥262.00
Previous CloseN/A
Volume447.50K
Average Volume (3M)624.53K
Market Cap
¥6.26B
Enterprise ValueN/A
Total Cash (Recent Filing)¥3.05B
Total Debt (Recent Filing)¥1.30B
Price to Earnings (P/E)―
Beta0.59
Next Earnings
Feb 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-24.10
Shares Outstanding54,041,080
10 Day Avg. Volume812,890
30 Day Avg. Volume624,533
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)2.14
Price to Sales (P/S)3.66
P/FCF Ratio-2.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Symbio Pharmaceuticals Limited News
4582 FAQ
What was Symbio Pharmaceuticals Limited’s price range in the past 12 months?
Symbio Pharmaceuticals Limited lowest stock price was ¥114.00 and its highest was ¥262.00 in the past 12 months.
What is Symbio Pharmaceuticals Limited’s market cap?
Symbio Pharmaceuticals Limited’s market cap is ¥6.26B.
When is Symbio Pharmaceuticals Limited’s upcoming earnings report date?
Symbio Pharmaceuticals Limited’s upcoming earnings report date is Feb 05, 2026 which is in 95 days.
How were Symbio Pharmaceuticals Limited’s earnings last quarter?
Symbio Pharmaceuticals Limited released its earnings results on Oct 30, 2025. The company reported -¥24.103 earnings per share for the quarter, missing the consensus estimate of N/A by -¥24.103.
Is Symbio Pharmaceuticals Limited overvalued?
According to Wall Street analysts Symbio Pharmaceuticals Limited’s price is currently Overvalued.
Does Symbio Pharmaceuticals Limited pay dividends?
Symbio Pharmaceuticals Limited does not currently pay dividends.
What is Symbio Pharmaceuticals Limited’s EPS estimate?
Symbio Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Symbio Pharmaceuticals Limited have?
Symbio Pharmaceuticals Limited has 54,041,080 shares outstanding.
What happened to Symbio Pharmaceuticals Limited’s price movement after its last earnings report?
Symbio Pharmaceuticals Limited reported an EPS of -¥24.103 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.855%.
Which hedge fund is a major shareholder of Symbio Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in JP:4582
Company Description
Symbio Pharmaceuticals Limited
Symbio Pharmaceuticals Limited (4582) is a specialized pharmaceutical company focused on the development, manufacturing, and distribution of innovative healthcare solutions. The company operates within the biotechnology and pharmaceutical sectors, offering a portfolio of prescription medications, over-the-counter drugs, and advanced therapeutic treatments. Symbio Pharmaceuticals is committed to advancing patient care by providing high-quality and accessible medical options tailored to various health conditions.
Technical Analysis
Solasia Pharma KK
―
Morishita Jintan Co., Ltd.
―
Medrx Co., Ltd.
―
Modalis Therapeutics Corporation
―
Cyfuse Biomedical K.K.
―